[HTML][HTML] Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial …
causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial …
[HTML][HTML] Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity
Background Immune checkpoint blockade (ICB) has revolutionized cancer immunotherapy.
However, most patients with cancer fail to respond clinically. One potential reason is the …
However, most patients with cancer fail to respond clinically. One potential reason is the …
[HTML][HTML] mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is highly transmissible and evades pre-established immunity. Messenger RNA …
variant is highly transmissible and evades pre-established immunity. Messenger RNA …
In Vitro Aerosol Exposure to Nanomaterials: From Laboratory to Environmental Field Toxicity Testing
Exposure to nanomaterials (NMs) is inevitable, requiring robust toxicological assessment to
understand potential environmental and human health effects. NMs are favored in many …
understand potential environmental and human health effects. NMs are favored in many …
[HTML][HTML] Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy
JH Azar, JP Evans, MH Sikorski, KB Chakravarthy… - JCI insight, 2023 - ncbi.nlm.nih.gov
We assessed vaccine-induced antibody responses to the SARS-CoV-2 ancestral virus and
Omicron variant before and after booster immunization in 57 patients with B cell …
Omicron variant before and after booster immunization in 57 patients with B cell …
Immunological Insights into the Therapeutic Roles of CD24Fc Against Severe COVID-19
ABSTRACT BACKGROUND SARS-CoV-2 causes COVID-19 through direct lysis of infected
lung epithelial cells, which releases damage-associated molecular patterns (DAMPs) and …
lung epithelial cells, which releases damage-associated molecular patterns (DAMPs) and …
Immunological Insights Into the Therapeutic Roles of CD24Fc Against Severe COVID-19 (preprint)
NJ Song, C Allen, AE Vilgelm, BP Riesenberg… - 2021 - pesquisa.bvsalud.org
ABSTRACT BACKGROUNDSARS-CoV-2 causes COVID-19 through direct lysis of infected
lung epithelial cells, which releases damage-associated molecular patterns (DAMPs) and …
lung epithelial cells, which releases damage-associated molecular patterns (DAMPs) and …